Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE Publishes Reimbursement Recommendation for Translarna™

February 22, 2023
Business Services

London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …

News
Press release

Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences

February 22, 2023
Business Services

Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …

News
Press release

Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis

February 22, 2023
Business Services

STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test

February 22, 2023
Medical Communications

Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …

News

Pfizer likely to be first to gain FDA approval for new RSV vaccine

February 22, 2023
Research and Development

The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …

News

Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)

February 21, 2023
Business Services

Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …

News
Press release

Unum UK expands employee digital health app

February 21, 2023
Medical Communications

Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …

News

CSL receives CMA from the European Commission for haemophilia B drug

February 21, 2023
Medical Communications

CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …

News

Hemab secures $135m in Series B funding for rare bleeding disorder treatment

February 21, 2023
Research and Development

Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …

News

Scancell shares encouraging results from phase 1/2 cancer trial

February 21, 2023
Research and Development

Scancell Holdings PLC have shared early results from its phase 1/2 cancer study which appear “very encouraging”, according to one …

News

AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium

February 20, 2023
Business Services

Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …

News
Press release

SMC recommends Opdivo® (nivolumab) for use post-surgery in specific urothelial cancer patients

February 20, 2023
Business Services

(Uxbridge, Middlesex, 13 February 2023) – The Scottish Medicines Consortium (SMC) has accepted Bristol Myers Squibb’s (BMS’) nivolumab for the …

News
Press release

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

February 20, 2023
Business Services

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Feature
Case study

Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic CastrationResistant Prostate Cance

February 20, 2023
Business Services

BEERSE, BELGIUM, 16 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the …

News
Press release
david-travis-avvzjc0ynbq-unsplash

FDA approves Apellis’ geographic atrophy treatment

February 20, 2023
Medical Communications

Apellis’ Syfovre (pegcetacoplan injection) is indicated for patients with geographic atrophy (GA) with or without subfoveal involvement, and has received …

News

Medtronic’s extravascular defibrillator receives CE mark

February 20, 2023
Medical Communications

Medtronic has received CE mark for its extravascular defibrillator. The Aurora EV-ICD™ MRI SureScan™ and Epsila EV™ MRI SureScan™ defibrillation …

News

Pfizer’s Lyme disease vaccine study cut due to protocol violations

February 20, 2023
Medical Communications

Valneva and Pfizer have seen their Lyme disease vaccine study cut down after some clinical trial sites were revealed to …

News

Stryker’s Q Guidance System received FDA clearance for cranial applications

February 20, 2023
Sales and Marketing

Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from …

News

Sun Pharma recalls at least 34,000 bottles of generic drug

February 13, 2023
Medical Communications

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, …

News

REGENXBIO presents interim phase 2 data from drug developed on NAVXpress™ platform

February 13, 2023
Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025